These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations. Khan A; Adil S; Qudsia HA; Waheed Y; Alshabrmi FM; Wei DQ Comput Biol Med; 2023 May; 158():106797. PubMed ID: 36966556 [TBL] [Abstract][Full Text] [Related]
4. Repositioning of anti-infective compounds against monkeypox virus core cysteine proteinase: a molecular dynamics study. Rabaan AA; Alshahrani FS; Garout M; Alissa M; Mashraqi MM; Alshehri AA; Alsaleh AA; Alwarthan S; Sabour AA; Alfaraj AH; AlShehail BM; Alotaibi N; Abduljabbar WA; Aljeldah M; Alestad JH Mol Divers; 2024 Apr; ():. PubMed ID: 38652365 [TBL] [Abstract][Full Text] [Related]
5. Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study. Lam TP; Tran VH; Mai TT; Lai NV; Dang BN; Le MT; Tran TD; Trinh DT; Thai KM Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232872 [TBL] [Abstract][Full Text] [Related]
7. Identification of the myxobacterial secondary metabolites Aurachin A and Soraphinol A as promising inhibitors of thymidylate kinase of the Monkeypox virus. Ali Y; Khan AA; Alanazi AM; Abdikakharovich SA; Shah JA; Ren ZG; Khattak S Mol Divers; 2024 Jan; ():. PubMed ID: 38183513 [TBL] [Abstract][Full Text] [Related]
9. Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations. Suleman M; Ahmad T; Shah K; Albekairi NA; Alshammari A; Khan A; Wei DQ; Yassine HM; Crovella S Front Pharmacol; 2023; 14():1328308. PubMed ID: 38269277 [TBL] [Abstract][Full Text] [Related]
10. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus. Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Kumar GS; Dubey A; Dwivedi VD; Azhar EI Sci Rep; 2023 Sep; 13(1):14570. PubMed ID: 37666979 [TBL] [Abstract][Full Text] [Related]
11. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002 [TBL] [Abstract][Full Text] [Related]
12. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I. Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105 [TBL] [Abstract][Full Text] [Related]
13. Identification of Antiviral Compounds against Monkeypox Virus Profilin-like Protein A42R from Bajrai LH; Alharbi AS; El-Day MM; Bafaraj AG; Dwivedi VD; Azhar EI Molecules; 2022 Nov; 27(22):. PubMed ID: 36431817 [TBL] [Abstract][Full Text] [Related]
14. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340 [TBL] [Abstract][Full Text] [Related]
15. Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study. Srivastava V; Naik B; Godara P; Das D; Mattaparthi VSK; Prusty D Mol Divers; 2024 Jun; 28(3):1093-1107. PubMed ID: 37079243 [TBL] [Abstract][Full Text] [Related]
16. Drug and Anti-Viral Peptide Design to Inhibit the Monkeypox Virus by Restricting A36R Protein. Miah MM; Tabassum N; Afroj Zinnia M; Islam ABMMK Bioinform Biol Insights; 2022; 16():11779322221141164. PubMed ID: 36570327 [TBL] [Abstract][Full Text] [Related]
17. Repurposing Anti-Dengue Compounds against Monkeypox Virus Targeting Core Cysteine Protease. Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Eltaib L; Alshehri A; Alsaiari AA; Kamal M; Alshammari AMA Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509664 [TBL] [Abstract][Full Text] [Related]
18. Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: An immunoinformatics approach. Bhattacharya M; Chatterjee S; Nag S; Dhama K; Chakraborty C Travel Med Infect Dis; 2022; 50():102481. PubMed ID: 36265732 [TBL] [Abstract][Full Text] [Related]
19. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study. Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762 [TBL] [Abstract][Full Text] [Related]
20. Molecular level investigation for identifying potential inhibitors against thymidylate kinase of monkeypox through Koirala S; Samanta S; Mahapatra S; Ursal KD; Poddar S; Kar P J Biomol Struct Dyn; 2023 Nov; ():1-14. PubMed ID: 37909473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]